Skip to main content
Clinical Trials/JPRN-UMIN000047522
JPRN-UMIN000047522
Recruiting
N/A

A multicenter study to elucidate the biological basis of behavioral and psychological symptoms of dementia (BPSD) using prospectively collected data of neuroimaging and blood biomarkers and to establish a method to predict the effects of non-pharmacological treatment for BPSD - J-BIRD-PNB Study

Japan Agency for Medical Research and Development0 sites150 target enrollmentApril 19, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Alzheimer&#39
Sponsor
Japan Agency for Medical Research and Development
Enrollment
150
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 19, 2022
End Date
March 31, 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)Patients who have abnormal findings on brain MRI that indicate other abnormalities than AD or DLB 2\)Patients who have history of organic brain diseases, such as head trauma, subarachnoid hemorrhage, or neurosurgery 3\)Patients who have history of psychiatric disorders, such as schizophrenia, bipolar disorder, alcoholism, or developmental disorder 4\)Patients who have a serious physical illness 5\)Patients who the researchers consider unsuitable for the research participants

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
N/A
Multicenter study for elucidating the pathophysiology of respiratory diseases using integrative omics analysis including the TGFb signal transduction system and genetic information analysis
JPRN-UMIN000043539Department of Respirology, Graduate School of Medicine, Chiba University60
Active, Not Recruiting
Phase 1
A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea.
EUCTR2015-004805-17-BEActelion Pharmaceuticals Ltd.200
Active, Not Recruiting
Phase 1
A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea.Clostridium difficile-associated diarrhea (CDAD)MedDRA version: 20.0Level: LLTClassification code 10012734Term: Diarrhea, Clostridium difficileSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: PTClassification code 10054236Term: Clostridium difficile infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10022661Term: Intestinal infection due to clostridium difficileSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: LLTClassification code 10012748Term: Diarrhoea, Clostridium difficileSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2015-004805-17-ESActelion Pharmaceuticals Ltd.1
Active, Not Recruiting
Phase 1
A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea.
EUCTR2015-004805-17-ITActelion Pharmaceuticals Ltd.200
Active, Not Recruiting
Phase 1
A clinical study to compare the effects of cadazolid with vancomycin in children with Clostridium difficile-associated diarrhea.
EUCTR2015-004805-17-HUActelion Pharmaceuticals Ltd.200